Quarterly report pursuant to Section 13 or 15(d)

Share-Based Payments (Tables)

v3.25.0.1
Share-Based Payments (Tables)
 3 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Activity
The transactions for RSUs for the three months ended December 31, 2024 were as follows:
RSUs Weighted-
average
Grant-date
Fair Value
Non-vested at September 30, 2024 1,707,349  $ 33.59 
Granted 520,900  25.52 
Contingent grant*
145,800  25.45 
Vested (423,295) 37.69 
Expired or forfeited (119,240) 38.00 
Non-vested at December 31, 2024 1,831,514  $ 27.38 
* In connection with its annual grant of equity awards, the Compensation Committee of the Board of Directors granted the President and Chief Executive Officer an award contingent upon the approval by the Company's shareholders of the Second Amended 2017 Plan. Such award consists of (i) time-based restricted stock units, which may settle into a maximum of 58,320 shares of Common Stock, subject to continued service to the Company through November 18, 2027, (ii) performance units, which may settle into a maximum of 43,740 shares of Common Stock at target levels, upon the Company achieving certain metrics based on return on invested capital (“ROIC”); and (iii) performance units, which may settle into a maximum of 43,740 shares of Common Stock at target levels upon stock price appreciation for the Common Stock.
Schedule of Assumptions Used in Estimating Fair Value The following table indicates the assumptions used in estimating the fair value of certain stock-based awards granted during the three-month period ended December 31, 2024.
Note 9.   Share-Based Payments (continued)

Three Months Ended
December 31, 2024
Expected volatility 31.8  %
Dividend yield 3.4  %
Average risk-free interest rate 4.2  %
Average expected term (years) 3.0